Designed by nature, developed for clinicians: creos xenogeneic assortment

Nobel Biocare

Thu. 23. March 2017

save

Sufficient bone quantity and quality are crucial for successful dental implant treatment. For this reason, Nobel Biocare introduced creos regenerative solutions, an array of options for guided hard- and soft-tissue regeneration. The latest addition to the line is the creos xenogain bone substitute, which, together with the creos xenoprotect resorbable collagen membrane, now offers clinicians a comprehensive set of xenogeneic options for a wide variety of indications.

Creos xenogain—A foundation for implant treatment
The creos xenogain bone substitute has been developed with clinical needs in mind. It has been proven to be biocompatible,[1–4] and unique processing methods remove the bovine proteins and lipids.[5, 6] The natural bone matrix of creos xenogain is characterised by micro- and interconnected macropore structures.[5, 6] With a calcium–phosphate ratio that reflects the composition in human bone and a low crystalline structure, creos xenogain is accepted by the body as a suitable framework for bone formation.[6–8] Bone substitutes in the creos xenogain range have a slow resorption rate and act as a long-lasting scaffold, maintaining space for bone regeneration.[2]

Creos xenogain—Easy to handle
For quick and easy application of the graft, creos xenogain is delivered sterile and comes in a vial, syringe or bowl ready for mixing. In addition, creos xenogain collagen is a 10 per cent collagen composite that is available as a block or in a syringe to aid application of the material for certain uses, such as extraction sockets. There is also a choice of two granule sizes and up to four volume options, offering a wide variety of alternatives depending on the clinical indication and preference.

Creos xenoprotect—The natural barrier
Once the bone substitute has been applied, the resorbable creos xenoprotect membrane can be used to hold it in place and act as a barrier to soft-tissue ingrowth. Manufactured using highly purified collagen and elastin fibres, it possesses outstanding handling properties that make it easy to reposition and unfold. Hydrated in seconds, but with minimal size increase, creos xenoprotect can be trimmed when dry for accurate placement at the graft site.[9]

Once hydrated, creos xenoprotect provides successful bone augmentation of dehiscence defects at implant sites.[12] It is stronger than other non-cross-linked and chemically cross-linked membranes,[10] and with a higher pull-out force, it provides advantages in terms of suture retention.[10] As it is highly resistant to degradation, creos xenoprotect offers prolonged protection of the graft site, and its excellent vascularisation behaviour and tissue compatibility support fast healing.[11]

Each product in the creos range of xenogeneic solutions has been developed to optimise treatment results. This comprehensive selection offers biocompatibility, easy handling, slow resorption and variety. Whichever of these scientific, evidence-based options the clinician chooses, he or she can be confident of building a reliable foundation for implant treatment success.[1–9, 11, 12]

More information about creos regenerative solutions, including articles and cases, can be found at www.nobelbiocare.com/creos.

A list of references can be obtained from the publisher.